Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach
Open Access
- 23 August 2016
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 31 (sup2) , 70-78
Abstract
Continuous efforts to identify sEH inhibitors using activity-guided fractionation have revealed 12 known compounds, 2–13, from Rheum undulatum. Compounds 2–13 and 1, which was obtained from the in-house library, were tested for inhibitory activity against sEH. Compounds 1–9, 11, and 12 were shown to have inhibitory activity, with IC50 values ranging from 2.5 ± 0.5 to 53.2 ± 4.4 μM. They were subjected to enzyme kinetic studies to explore the binding mode between the ligand and receptor. Based on our results, compounds 1, 2, 5–9, and 11 (mixed type) and compounds 3 and 12 (noncompetitive type) had a preferred allosteric site. Compound 4 was identified as a competitive-type interaction in the active site. Molecular docking studies revealed the interacting residues and binding energy between sEH and inhibitors. Additionally, molecular dynamics provided detailed information on the interaction between the ligand and receptor.Keywords
This publication has 24 references indexed in Scilit:
- Chemical constituents from the root of Polygonum multiflorum and their soluble epoxide hydrolase inhibitory activityArchives of Pharmacal Research, 2014
- Evaluation of the protective effect of Rhei Radix et Rhizoma against α-naphthylisothiocyanate induced liver injury based on metabolic profile of bile acidsJournal of Ethnopharmacology, 2012
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- Genetic Diversity of Rhubarb CultivarsJournal of the American Society for Horticultural Science, 2008
- DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammationTrends in Pharmacological Sciences, 2007
- Antidiabetic stilbene and anthraquinone derivatives fromRheum undulatumArchives of Pharmacal Research, 2005
- Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseasesAmerican Journal of Physiology-Renal Physiology, 2005
- Pharmacokinetic analysis of rhein in Rheum undulatum L.Journal of Ethnopharmacology, 2003
- Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosidesBioorganic & Medicinal Chemistry, 2001
- Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived EicosanoidsScience, 1999